Search Results - "Chamoun, Mira"
-
1
Microglial activation and tau propagate jointly across Braak stages
Published in Nature medicine (01-09-2021)“…Compelling experimental evidence suggests that microglial activation is involved in the spread of tau tangles over the neocortex in Alzheimer’s disease (AD)…”
Get full text
Journal Article -
2
Aβ-induced vulnerability propagates via the brain’s default mode network
Published in Nature communications (04-06-2019)“…The link between brain amyloid-β (Aβ), metabolism, and dementia symptoms remains a pressing question in Alzheimer’s disease. Here, using positron emission…”
Get full text
Journal Article -
3
Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer's disease
Published in Neuropsychopharmacology (New York, N.Y.) (01-04-2022)“…The clinical and pathophysiological correlates of locus coeruleus (LC) degeneration in Alzheimer's disease (AD) could be clarified using a method to index LC…”
Get full text
Journal Article -
4
APOEε4 potentiates the relationship between amyloid-β and tau pathologies
Published in Molecular psychiatry (01-10-2021)“…APOEε4 is the most well-established genetic risk factor for sporadic Alzheimer’s disease and is associated with cerebral amyloid-β. However, the association…”
Get full text
Journal Article -
5
Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease
Published in Molecular psychiatry (01-10-2021)“…Neurofilament light chain (NFL) measurement has been gaining strong support as a clinically useful neuronal injury biomarker for various neurodegenerative…”
Get full text
Journal Article -
6
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages
Published in Brain (London, England : 1878) (16-12-2021)“…Tracking longitudinal tau tangles accumulation across the Alzheimer's disease continuum is crucial to better understand the natural history of tau pathology…”
Get full text
Journal Article -
7
In vivo quantification of neurofibrillary tangles with [ 18 F]MK-6240
Published in Alzheimer's research & therapy (31-07-2018)“…Imaging agents capable of quantifying the brain's tau aggregates will allow a more precise staging of Alzheimer's disease (AD). The aim of the present study…”
Get full text
Journal Article -
8
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease
Published in EBioMedicine (01-02-2022)“…Phosphorylated tau (p-tau) epitopes in cerebrospinal fluid (CSF) are accurate biomarkers for a pathological and clinical diagnosis of Alzheimer's disease (AD)…”
Get full text
Journal Article -
9
Biomarker modeling of Alzheimer's disease using PET-based Braak staging
Published in Nature aging (01-06-2022)“…Gold-standard diagnosis of Alzheimer's disease (AD) relies on histopathological staging systems. Using the topographical information from [ F]MK6240 tau…”
Get full text
Journal Article -
10
[11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
Published in Nature communications (19-07-2022)“…Alzheimer’s disease (AD) is characterized by the brain accumulation of amyloid-β and tau proteins. A growing body of literature suggests that epigenetic…”
Get full text
Journal Article -
11
Cholinergic Potentiation Alters Perceptual Eye Dominance Plasticity Induced by a Few Hours of Monocular Patching in Adults
Published in Frontiers in neuroscience (31-01-2019)“…A few hours of monocular deprivation with a diffuser eye patch temporarily strengthens the contribution of the deprived eye to binocular vision. This shift in…”
Get full text
Journal Article -
12
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET
Published in EBioMedicine (01-02-2022)“…Tau in Alzheimer's disease (AD) is assessed via cerebrospinal fluid (CSF) and Positron emission tomography (PET). Novel methods to detect phosphorylated tau…”
Get full text
Journal Article -
13
Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's disease
Published in Alzheimer's research & therapy (29-03-2021)“…To investigate the association of plasma pTau181, assessed with a new immunoassay, with neurodegeneration of white matter and gray matter cross-sectionally and…”
Get full text
Journal Article -
14
Publisher Correction: Microglial activation and tau propagate jointly across Braak stages
Published in Nature medicine (01-11-2021)Get full text
Journal Article -
15
Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
Published in Nature communications (03-10-2022)Get full text
Journal Article -
16
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals
Published in Alzheimer's & dementia : diagnosis, assessment & disease monitoring (01-12-2019)“…Neurofilament light chain (NfL) is a promising blood biomarker to detect neurodegeneration in Alzheimer's disease (AD) and other brain disorders. However,…”
Get full text
Journal Article -
17
18F-MK-6240 PET for early and late detection of neurofibrillary tangles
Published in Brain (London, England : 1878) (01-09-2020)“…Braak stages of tau neurofibrillary tangle accumulation have been incorporated in the criteria for the neuropathological diagnosis of Alzheimer's disease. It…”
Get full text
Journal Article -
18
CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals
Published in Alzheimer's research & therapy (22-12-2022)“…Cerebrospinal fluid (CSF) tau biomarkers are reliable diagnostic markers for Alzheimer's disease (AD). However, their strong association with amyloid pathology…”
Get full text
Journal Article -
19
Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer's disease
Published in Alzheimer's research & therapy (04-06-2022)“…Synaptic dysfunction and degeneration are central to Alzheimer's disease (AD) and have been found to correlate strongly with cognitive decline. Thus, studying…”
Get full text
Journal Article -
20
Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease
Published in Alzheimer's & dementia : translational research & clinical interventions (2021)“…Background Neuropsychiatric symptoms (NPS) are frequent in aging and Alzheimer's disease (AD). Here we study the relationship between NPS and AD pathologies in…”
Get full text
Journal Article